related documents
- PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results Conferences
- PO-44 Incidence of venous thromboembolism in patients undergoing thoracotomy for cancer Conferences